• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Illumina

Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics

by Fred Pennic 10/12/2022 Leave a Comment

Genetics Startup Pleno Launches Out of Stealth with $15M

What You Should Know: - Pleno, Inc, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research raises $40M in Series A funding led by Deerfield Management and Foresite Capital.  - The funding will accelerate the development of Pleno’s Hypercoding™ instrument platform, called RAPTOR ™, which is slated for early customer access in 2023 and full availability in 2024. Release below
Read More

Healthcare & Life Science M&A Activity Plummets 1H’22

by Syed Hamza Sohail 08/05/2022 Leave a Comment

Healthcare & Life Science M&A Activity Plummets 1H’22

What You Should Know: - The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%. - Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector. Key Trends and
Read More

Genetics Startup Pleno Launches Out of Stealth with $15M

by Fred Pennic 05/25/2022 Leave a Comment

Genetics Startup Pleno Launches Out of Stealth with $15M

What You Should Know: - Pleno, a multi-omics startup, is emerging out of stealth with a $15M Pre-Series A financing and Greg Lucier as Chairman of the Board of Directors. Founded by Pieter van Rooyen, a well-known biotech engineer who built and sold his last company, Edico Genome, to Illumina for $100M. Edico's Dragen technology has become a staple in genetics research.  - Pleno's Hypercoding technology has the potential to revolutionize biological target detection for
Read More

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

by Jasmine Pennic 01/05/2022 Leave a Comment

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

What You Should Know: - Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting. - Together, the two companies will work to better understand biomarker testing patterns among clinicians, which have become foundational in identifying treatment options for cancer patients. The insights gleaned from this
Read More

Illumina, Sequoia Capital China Launches Genomics Incubator in China

by Fred Pennic 02/01/2021 Leave a Comment

Illumina, Sequoia Capital China Launches Genomics Incubator in China

What You Should Know: - Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics. - Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in building genomics companies with the unparalleled track record of Illumina Accelerator in San Francisco Bay Area and Cambridge, UK. - Sequoia Capital China will dedicate to
Read More

LetsGetChecked Nabs $71M for Direct-to-Consumer At-Home Health Testing

by Fred Pennic 05/06/2020 Leave a Comment

LetsGetChecked Nabs $71M for Direct-to-Consumer At-Home Health Testing

LetsGetChecked, a leading direct-to-consumer at-home health testing and insights company, today announced the closing of $71 million in its Series C round of financing co-led by Illumina Ventures and HLM Venture Partners. The round also includes new investors Deerfield, CommonFund Capital, and Angeles Investments and existing investors Transformation Capital, Optum Ventures, and Qiming Venture Partners USA. Nick Naclerio, Founding Partner at Illumina Ventures and Steven Tolle, Partner at HLM
Read More

Microsoft, Adaptive, Providence Partner to Decode COVID-19 Immune Response

by Fred Pennic 03/20/2020 Leave a Comment

To generate immune response data, Adaptive will open enrollment in April to collect de-identified blood samples, using a LabCorp-enabled mobile phlebotomy service, from individuals diagnosed with or recovered from COVID-19 in a virtual clinical trial managed by Covance. Immune cell receptors from these blood samples will be sequenced using Illumina platform technology and mapped to SARS-CoV-2-specific antigens that will have been confirmed by Adaptive’s proprietary immune medicine platform to induce an immune response. The immune response signature found from the initial discovery work and the initial set of samples will be uploaded to the open data access portal. Leveraging Microsoft’s hyperscale machine learning capabilities and the Azure cloud platform, the accuracy of the immune response signature will be continuously improved and updated online in real time as more trial samples are sequenced from the study. Providence to Serve as Clinical Collaborator To expedite the development and relevance of the immune response signature across the global population, the companies are seeking additional participation from institutions and research groups around the world to contribute blood samples to this open data initiative. Providence, a large health system with 51 hospitals, including the one near Seattle that treated the first U.S. COVID-19 patient, is an initial clinical collaborator. “The solution to COVID-19 is not likely going to come from one person, one company or one country. This is a global issue, and it will be a global effort to solve it,” said Peter Lee, corporate vice president, AI and Research, Microsoft. “Making critical information about the immune response accessible to the broader research community will help advance ongoing and new efforts to solve this global public health crisis, and we can accomplish this goal through our proven TCR-Antigen mapping partnership with Adaptive.” Timing & Enrollment Timing and enrollment details about the upcoming study and the open data access portal will be coming soon. Institutions or collaborators interested in contributing blood samples can direct inquiries to COVID19ImmuneResponse@adaptivebiotech.com.

What You Should Know: - Microsoft and Adaptive Biotechnologies have expanded their partnership to map the human immune response to COVID-19 and advance our understanding of the disease. - Data from this study will be made available through an open-access portal to help researchers, public health organizations and industry improve diagnostics, help triage patients based on the immune response to the disease, and inform vaccine discovery for COVID-19. - Other industry leaders including
Read More

Health Data Privacy: Why Eroding Public Trust Harms Medical Research

by Scott Kahn, Ph.D, Chief Information Officer at LunaPBC 01/08/2020 Leave a Comment

Healthcare Data Privacy: Why Eroding Public Trust Harms Medical Research

Using Data Privacy to Empower Health Research The importance of data security and data privacy policies have recently come under scrutiny due to revelations around Google’s Project Nightingale. The initiative with Ascension, the nation’s largest nonprofit health system, granted Google access to medical records of more than 50 million individuals in 21 states and may hinder the trajectory of health discovery by eroding “consumer” trust.  While historically it might have been a safe harbor to
Read More

Sun Genomics Delivers Personalized Probiotics In Only 6 Weeks to Address Gut Health Issues

by Fred Pennic 10/25/2019 Leave a Comment

Sun Genomics Delivers Personalized Probiotics In Only 6 Weeks to Address Gut Health Issues

- Sun Genomics launches personalized probiotic solution to identify and address individual gut health issues to improve the health of millions of Americans. - Solution delivers precise probiotic formula required for each person to address their own unique gut health issues in just six weeks. - Sun Genomics Floré includes a kit to collect a micro-stool sample, a full microbiome analysis report, and a 90-day supply of precision probiotics.Sun Genomics today launched the first customized
Read More

MedAnswers Raises $5M for Scientifically, Clinically Validated FertilityAnswers App

by Jasmine Pennic 08/14/2019 Leave a Comment

MedAnswers Raises $5 Million Seed Round

MedAnswers, a health tech company has raised $5 million in seed round funding led by Special Situations’ Life Sciences Innovation (LSI) Fund, managed by David Sable, with Viking Global Investors also participating. MedAnswers is leveraging technology, genetics and other health data to match those struggling to conceive to a curated network of fertility experts and solutions to help users conceive faster. The company is a graduate of the 7th cycle of Illumina Accelerator. FertilityAnswers AppThe
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |